WL
Therapeutic Areas
Avalon GloboCare Pipeline
| Drug | Indication | Phase |
|---|---|---|
| KetoAir™ Breathalyzer | Ketosis Monitoring / Metabolic Health | Commercial |
| QTY Code Cytokine Receptors (Six Variants) | Inflammatory & Immune Conditions (Research Platform) | Pre-clinical |
Leadership Team at Avalon GloboCare
ML
Meng Li
Interim Chief Executive Officer and Chief Operating Officer
LI
Luisa Ingargiola
Chief Financial Officer
MM
Michael Mathews
Director
SS
Steven Sanders, Esq.
Lead Independent Director
LF
Lourdes Felix
Director
SZ
Shuguang Zhang
Principal Investigator (MIT Collaborator for QTY Code Platform)